0001415889-18-001204.txt : 20180801
0001415889-18-001204.hdr.sgml : 20180801
20180801160535
ACCESSION NUMBER: 0001415889-18-001204
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180730
FILED AS OF DATE: 20180801
DATE AS OF CHANGE: 20180801
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: AHMED NADIM
CENTRAL INDEX KEY: 0001731193
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34912
FILM NUMBER: 18984753
MAIL ADDRESS:
STREET 1: C/O CELGENE CORPORATION
STREET 2: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CELGENE CORP /DE/
CENTRAL INDEX KEY: 0000816284
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 222711928
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
BUSINESS PHONE: (908)673-9000
MAIL ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
4
1
form4-08012018_040820.xml
X0306
4
2018-07-30
0000816284
CELGENE CORP /DE/
CELG
0001731193
AHMED NADIM
C/O CELGENE CORPORATION
86 MORRIS AVENUE
SUMMIT
NJ
07901
false
true
false
false
PRES., HEMATOLOGY AND ONCOLOGY
Stock Option (right to buy)
88.91
2018-07-30
4
A
0
10548
0
A
2028-07-30
Common Stock
10548
10548
D
Option is immediately exercisable and will vest in four equal annual installments commencing on July 30, 2019.
The option was issued pursuant to the Company's 2017 Stock Incentive Plan.
/s/ Mark J. Alles, Attorney-in-Fact
2018-08-01